AG
TAK icon

Advisor Group’s Takeda Pharmaceutical TAK Stock Holding History

Advisor Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$509K Buy
25,876
+5,546
+27% +$106K ﹤0.01% 1654
2019
Q3 		$351K Buy
20,330
+2,406
+13% +$41.6K ﹤0.01% 1884
2019
Q2 		$317K Buy
17,924
+3,770
+27% +$68.6K ﹤0.01% 1957
2019
Q1 		$290K Buy
14,154
+7,359
+108% +$148K ﹤0.01% 1992
2018
Q4 		$114K Buy
+6,795
New +$115K ﹤0.01% 2543

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Advisor Group's TAK Position: Q4 2019 in Review

Advisor Group increased its Takeda Pharmaceutical (TAK) stake by 27% in Q4 2019, buying an estimated $106K and bringing the position to 25,876 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

Advisor Group first reported a position in TAK in Q4 2018 and has held it in 5 quarters since. 339 funds tracked by Wall St. Rank hold TAK as of Q4 2019.

  • Advisor Group held 25,876 shares of Takeda Pharmaceutical worth $509K as of Q4 2019.
  • Advisor Group bought 5,546 Takeda Pharmaceutical shares in Q4 2019, an estimated $106K.
  • Takeda Pharmaceutical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1654 holding.
  • Advisor Group first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 5 quarters since.
  • 339 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.